What these products are not: a treatment for obesity, diabetes, or any medical condition, and not an alternative to a GLP-1 medication
Step-by-Step Reconstitution Protocol: Our Team's Method Precision is a process
Finding the right approach often requires personalized medical guidance
While insurers may point to diabetes, sleep apnea, or blood-pressure fluctuations as causes, a documented timeline showing a recent start or dose increase of a GLP-1 drug followed by sudden NAION strengthens a potential claim
Excluding the inherent limitations that are known to exist with dietary self-reports, we expressed caloric intake relative to body mass, and based on the fact that there were no significant changes over the course of the 8-week study for the dietary variables, and that GSH + CIT did not consume more total calories or protein than the other two groups, dietary intake can likely be ruled out as a possible confounding variable for the increased lean mass